Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b82f0f38f6f84aaba2737cb84b1ff646 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8c0982b0f02b1ed6d20a315370a3a3a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f7e0e044417207ce8d25a7772cfd7f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_54d9e1c6d2367d6ec841a92acf08a06c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e3c952ff24523fe80356c5944f5313b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-051 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N15-042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2015-149 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2015-1497 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-124 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-21 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0645 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N63-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0786 |
filingDate |
2010-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00b6ba78ec7d1cd74f63ddd8549a214d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d107f72ae1630fbbf8dd4f33996b8dbd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1fe4c68f16f0c05231a09ee08007bd7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14155134a004ac28cca6b7cfcaf33f5b |
publicationDate |
2010-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2010096177-A1 |
titleOfInvention |
Isolated monocyte populations and related therapeutic applications |
abstract |
The invention provides methods of using isolated monocyte populations to treat subjects suffering from various ocular vascular disease or ocular degenerative disorders. The present invention also provides novel methods for isolating substantially pure monocyte populations. The methods involve extracting a blood sample or a bone marrow sample from a subject, debulking red blood cells from the sample, and then separating remaining red blood cells and other cell types in the sample from monocytes. Instead of using any selection or labeling agents, the red blood cells and other cell types are separated from monocytes based on their size, granularity or density. The isolated monocytes can be further activated in vitro or ex vivo prior to being administered to a subject. Isolated cell populations containing substantially pure CD14+/CD33+ monocytes are also provided in the invention. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102257163-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2014269935-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160016874-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10188679-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014188436-A1 |
priorityDate |
2009-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |